Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy.

ABSTRACT:

SUBMITTER: Dispenza MC 

PROVIDER: S-EPMC7297295 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature